Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity.
about
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infectionThe cell biology of HIV-1 and other retrovirusesTetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathwaysPlunder and stowaways: incorporation of cellular proteins by enveloped virusesThe double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidationcis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptorContribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionIn vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency virusesSodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachmentEfficient production of HIV-1 virus-like particles from a mammalian expression vector requires the N-terminal capsid domainHIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA)Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1Human follicular dendritic cells remain uninfected and capture human immunodeficiency virus type 1 through CD54-CD11a interactionDistinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage.Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assayCellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection.Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41Stimulation of HIV-1 replication in immature dendritic cells in contact with primary CD4 T or B lymphocytes.Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases.Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection.CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cellsCellular proteins associated with the interior and exterior of vesicular stomatitis virus virionsVirus maturation by budding.TRAF6 and IRF7 control HIV replication in macrophages.The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replicationContribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.Endocytosis-mediated HIV-1 entry and its significance in the elusive behavior of the virus in astrocytes.Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.COP9 signalosome component JAB1/CSN5 is necessary for T cell signaling through LFA-1 and HIV-1 replication.Intercellular adhesion molecule 1 promotes HIV-1 attachment but not fusion to target cells.Cell-to-Cell Transmission of HIV-1 Is Required to Trigger Pyroptotic Death of Lymphoid-Tissue-Derived CD4 T CellsHTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated.Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120.Selective acquisition of host-derived ICAM-1 by HIV-1 is a matrix-dependent process.WFDC1 expression identifies memory CD4 T-lymphocytes rendered vulnerable to cell-cell HIV-1 transfer by promoting intercellular adhesive junctions
P2860
Q21245045-005AB668-5C7A-41E1-A06C-4C2854AF4696Q21245199-BB939598-F4E1-497B-ADC2-E4FEEC64A93DQ24519068-FD103972-BC49-4FD5-9944-982AE6F4562BQ24524170-0420FA05-A87A-4468-B3FC-74C933F2C93FQ24525207-316529C8-CC01-472B-8A77-AA8BF021F6F5Q24530658-7AAB72AC-9B2C-477D-9A84-3F66CEFB74A1Q24550678-4D292D4A-B721-4AED-B962-E9B913332210Q24552626-486AB52B-D9DC-4FC9-9104-433E873B1EE6Q28343806-3C982419-7FA5-4CD3-A86F-0378F27A6794Q28478202-89407D48-35F9-4EF0-A48D-F9A8018B277EQ28741718-25481FB3-B4FA-457F-B1E9-753EF0DE8CD4Q30447936-5D9AB2CE-3809-4CED-BBF1-1E1CCD1E4F73Q33646010-303B67B1-95FD-4C9D-821A-43077E6C7D90Q33780497-3B77D1E5-46E3-42DF-B199-0658DE3BA2D6Q33782387-AE000427-7EC1-49FC-B1BF-795825C6635BQ33782608-C8AA7B3D-AEB9-4653-8796-2DE0E92916C2Q33783714-EF938737-83DE-44CB-8C28-196B8DDC4A28Q33783773-F4E18512-ECEE-458C-8D42-2524155C4645Q33794467-02E4968D-A03C-4D9D-9803-50D1D73AE9A9Q33801455-BB081938-CBC5-4E42-B3BD-64D1CD912CB0Q33807129-DBDB45C7-2983-4A90-8ED1-7BB359516316Q33826717-291FD919-E850-431F-99E3-812AB76BCB1DQ33827027-1C90C28E-2B05-4713-A04C-FE8CD240EAA3Q33841004-B50F21B9-281F-4D63-9210-F0D1D97C7DB9Q33874273-D4BAF3B7-AB36-4F32-8431-469B71D4AA56Q34020589-FAF4809E-0521-4E99-B107-A844A1CD5BAEQ34068037-E4BA39EB-6980-4A31-86E3-68D82798BC77Q34091270-B5BA1510-8551-4B01-9A66-D0758C861426Q34141571-24B21DCF-364B-4A5B-BC27-0C33454040EFQ34193846-6CD38B93-99EC-42F7-AF37-9174D8077F5FQ34264416-95313F65-18CA-446D-ACE6-884ADBE2FD5BQ34347594-69356793-01BD-4DBC-8250-67C5499196D3Q34357068-3B3A9404-D62A-4B52-A281-0ABE4C7DCE18Q34388158-6A109D77-FE08-4E2C-B91F-9629FE96CA8EQ34412803-4925D51F-1862-41BA-96A6-9D0A04EAA771Q34491597-CE62538B-1E72-4A05-8F1F-7B89866134F5Q34599506-F2A79899-FFBD-42A4-9695-D2A40F141AF7Q34983331-34066CCC-7C03-460E-8CDA-39AE3CF931D4Q34992721-58ADEEAB-06C6-4816-93FB-F7A41F3A32B6Q35027206-917D6066-8F56-47FE-ACB2-8863F1D96BF5
P2860
Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Host-derived ICAM-1 glycoprote ...... and enhance viral infectivity.
@ast
Host-derived ICAM-1 glycoprote ...... and enhance viral infectivity.
@en
type
label
Host-derived ICAM-1 glycoprote ...... and enhance viral infectivity.
@ast
Host-derived ICAM-1 glycoprote ...... and enhance viral infectivity.
@en
prefLabel
Host-derived ICAM-1 glycoprote ...... and enhance viral infectivity.
@ast
Host-derived ICAM-1 glycoprote ...... and enhance viral infectivity.
@en
P2093
P2860
P1433
P1476
Host-derived ICAM-1 glycoprote ...... and enhance viral infectivity
@en
P2093
Lamontagne G
Tremblay M
P2860
P304
P407
P577
1997-05-01T00:00:00Z